These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21414644)

  • 1. [Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the clinical experience of a University Hospital (1989-2008)].
    Ferrándiz-Pulido C; García-Fernández D; Gómez-Morell P; Palao R; García-Patos V
    Med Clin (Barc); 2011 May; 136(13):583-7. PubMed ID: 21414644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
    Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.
    Yang SC; Hu S; Zhang SZ; Huang JW; Zhang J; Ji C; Cheng B
    J Immunol Res; 2018; 2018():4320195. PubMed ID: 29607330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China.
    Sun J; Liu J; Gong QL; Ding GZ; Ma LW; Zhang LC; Lu Y
    Drug Des Devel Ther; 2014; 8():2539-47. PubMed ID: 25548516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.
    Yamane Y; Aihara M; Ikezawa Z
    Allergol Int; 2007 Dec; 56(4):419-25. PubMed ID: 17713361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience.
    Lalosevic J; Nikolic M; Gajic-Veljic M; Skiljevic D; Medenica L
    Int J Dermatol; 2015 Aug; 54(8):978-84. PubMed ID: 25385069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
    Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
    Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.